Phase Separation Enhanced PROTAC for Highly Efficient Protein Degradation

被引:1
|
作者
Yu, Xiaolin [1 ]
Hu, Wenrui [1 ]
Dong, Hang [1 ]
Zhao, Tian [1 ]
Wang, Xiaotian [1 ]
Chen, Long [1 ]
Xue, Song [1 ]
Li, Jin-Ping [2 ,3 ]
Luo, Shi-Zhong [1 ]
机构
[1] Beijing Univ Chem Technol, Coll Life Sci & Technol, State Key Lab Chem Resource Engn, Beijing 100029, Peoples R China
[2] Beijing Univ Chem Technol, Beijing Adv Innovat Ctr Soft Matter Sci & Engn, Beijing 100029, Peoples R China
[3] Uppsala Univ, Dept Med Biochem & Microbiol, Uppsala, Sweden
基金
中国国家自然科学基金;
关键词
TRANSITIONS; MODALITY; TARGET;
D O I
10.1021/acs.biomac.4c00424
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Biomacromolecular condensates formed via phase separation establish compartments for the enrichment of specific compositions, which is also used as a biological tool to enhance molecule condensation, thereby increasing the efficiency of biological processes. Proteolysis-targeting chimeras (PROTACs) have been developed as powerful tools for targeted protein degradation in cells, offering a promising approach for therapies for different diseases. Herein, we introduce an intrinsically disordered region in the PROTAC (denoted PSETAC), which led to the formation of droplets of target proteins in the cells and increased degradation efficiency compared with PROTAC without phase separation. Further, using a nucleus targeting intrinsically disordered domain, the PSETAC was able to target and degrade nuclear-located proteins. Finally, we demonstrated intracellular delivery of PSETAC using lipid nanoparticle-encapsulated mRNA (mRNA-LNP) for the degradation of the endogenous target protein. This study established the PSETAC mRNA-LNP method as a potentially translatable, safe therapeutic strategy for the development of clinical applications based on PROTAC.
引用
收藏
页码:4374 / 4383
页数:10
相关论文
共 50 条
  • [31] PROTAC-biomacromolecule conjugates for precise protein degradation in cancer therapy: A review
    Wang, Chao
    Zhang, Yujing
    Yu, Wanpeng
    Xu, Jiazhen
    Xing, Dongming
    INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES, 2024, 261
  • [32] Recent Developments in PROTAC-Mediated Protein Degradation: From Bench to Clinic
    Hu, Zhenyi
    Crews, Craig M.
    CHEMBIOCHEM, 2022, 23 (02)
  • [33] Development of p300-targeting PROTAC degraders with enhanced selectivity and onset of degradation
    Marsh, Graham P.
    Goggins, Sean
    Bosnakovski, Darko
    Kyba, Michael
    Ojeda, Samuel
    Harrison, Drew A.
    Ott, Christopher J.
    Maple, Hannah J.
    CANCER RESEARCH, 2023, 83 (07)
  • [34] Proteolysis-targeting chimera (PROTAC) for targeted protein degradation and cancer therapy
    Li, Xin
    Song, Yongcheng
    JOURNAL OF HEMATOLOGY & ONCOLOGY, 2020, 13 (01)
  • [35] Proteolysis-targeting chimera (PROTAC) for targeted protein degradation and cancer therapy
    Xin Li
    Yongcheng Song
    Journal of Hematology & Oncology, 13
  • [36] Degradation characteristics of highly efficient degradation bacteria of imazapyr
    Wang, Xue-Dong
    Ou, Xiao-Ming
    Wang, Hui-Li
    Fan, De-Fang
    Zhongguo Huanjing Kexue/China Environmental Science, 2003, 23 (01):
  • [37] Aerogel for Highly Efficient Photocatalytic Degradation
    Yang, Xue-Chun
    Zhao, Jing-Tai
    GELS, 2024, 10 (02)
  • [38] PROTAC protein degraders to drug the undruggable enter phase 3 trials
    Arnold, Carrie
    NATURE MEDICINE, 2024, 30 (11) : 3030 - 3031
  • [39] Highly Carboxylated, Cellular Structured, and Underwater Superelastic Nanofibrous Aerogels for Efficient Protein Separation
    Fu, Qiuxia
    Si, Yang
    Duan, Cheng
    Yan, Zishuo
    Liu, Lifang
    Yu, Jianyong
    Ding, Bin
    ADVANCED FUNCTIONAL MATERIALS, 2019, 29 (13)
  • [40] Induced protein degradation of anaplastic lymphoma kinase (ALK) by proteolysis targeting chimera (PROTAC)
    Kang, Chung Hyo
    Lee, Dong Ho
    Lee, Chong Ock
    Ha, Jae Du
    Park, Chi Hoon
    Hwang, Jong Yeon
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2018, 505 (02) : 542 - 547